Pages that link to "Q44116957"
Jump to navigation
Jump to search
The following pages link to Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies (Q44116957):
Displaying 50 items.
- Pathogenesis of human immunodeficiency virus infection (Q24634681) (← links)
- Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant (Q24815687) (← links)
- Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodies (Q28477253) (← links)
- HIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscape (Q28487168) (← links)
- Rapid evolution of the neutralizing antibody response to HIV type 1 infection (Q29618603) (← links)
- Appreciating HIV type 1 diversity: subtype differences in Env. (Q30375834) (← links)
- Escape from autologous neutralizing antibodies in acute/early subtype C HIV-1 infection requires multiple pathways (Q33504599) (← links)
- Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection (Q33504604) (← links)
- The cat and mouse of HIV-1 antibody escape (Q33504607) (← links)
- A strategy for eliciting antibodies against cryptic, conserved, conformationally dependent epitopes of HIV envelope glycoprotein (Q33522232) (← links)
- R5 clade C SHIV strains with tier 1 or 2 neutralization sensitivity: tools to dissect env evolution and to develop AIDS vaccines in primate models (Q33640144) (← links)
- Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. (Q33784911) (← links)
- Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis (Q33813025) (← links)
- Nonpathogenic simian immunodeficiency virus infection of sooty mangabeys is not associated with high levels of autologous neutralizing antibodies (Q33877434) (← links)
- Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status (Q33908859) (← links)
- Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count (Q33998352) (← links)
- Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution (Q34092644) (← links)
- Autologous neutralizing antibody to human immunodeficiency virus-1 and replication-competent virus recovered from CD4+ T-cell reservoirs in pediatric HIV-1-infected patients on HAART. (Q34103202) (← links)
- Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies (Q34201595) (← links)
- Superinfection by discordant subtypes of HIV-1 does not enhance the neutralizing antibody response against autologous virus (Q34312037) (← links)
- Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa (Q34332009) (← links)
- Specificity of the autologous neutralizing antibody response (Q34415389) (← links)
- Neutralizing antiviral antibody responses (Q34419527) (← links)
- Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120. (Q34464860) (← links)
- The B cell response is redundant and highly focused on V1V2 during early subtype C infection in a Zambian seroconverter (Q34485260) (← links)
- Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1 (Q34648079) (← links)
- Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis (Q34720373) (← links)
- Public versus personal serotypes of a viral quasispecies. (Q35022653) (← links)
- Viral persistence in vivo through selection of neutralizing antibody-escape variants. (Q35080884) (← links)
- An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus (Q35109028) (← links)
- epitopes immediately below the base of the V3 loop of gp120 as targets for the initial autologous neutralizing antibody response in two HIV-1 subtype B-infected individuals (Q35192660) (← links)
- Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection (Q35369891) (← links)
- Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1 (Q35665921) (← links)
- Enhanced HIV-1 neutralization by antibody heteroligation (Q35735385) (← links)
- Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gp120-gp41 interactive regions. (Q35835261) (← links)
- Longitudinal Analysis of Cerebrospinal Fluid and Plasma HIV-1 Envelope Sequences Isolated From a Single Donor with HIV Asymptomatic Neurocognitive Impairment (Q35838394) (← links)
- Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates. (Q35841780) (← links)
- Comparison of heterologous neutralizing antibody responses of human immunodeficiency virus type 1 (HIV-1)- and HIV-2-infected Senegalese patients: distinct patterns of breadth and magnitude distinguish HIV-1 and HIV-2 infections (Q35857480) (← links)
- Mechanisms of human immunodeficiency virus Type 1 (HIV-1) neutralization: irreversible inactivation of infectivity by anti-HIV-1 antibody (Q35866030) (← links)
- Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1 (Q35880498) (← links)
- Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS (Q35895520) (← links)
- Association of enhanced HIV-1 neutralization by a single Y681H substitution in gp41 with increased gp120-CD4 interaction and macrophage infectivity (Q35956940) (← links)
- Potent human immunodeficiency virus-neutralizing and complement lysis activities of antibodies are not obligatorily linked (Q36540060) (← links)
- Evaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1. (Q36625106) (← links)
- Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization (Q36635390) (← links)
- Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. (Q36636446) (← links)
- Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors (Q36856960) (← links)
- Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies (Q37033269) (← links)
- Neutralization of Infectivity of Diverse R5 Clinical Isolates of Human Immunodeficiency Virus Type 1 by gp120-Binding 2′F-RNA Aptamers (Q37059618) (← links)
- Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment (Q37410770) (← links)